FDA.reportPublic FDA data

Application 213110

Type
ANDA
Sponsor
LANNETT CO INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CLOBAZAMCLOBAZAMSUSPENSION;ORAL2.5MG/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0527-5301ClobazamclobazamLannett Company, Inc.ANDACurrent
0527-5301ClobazamclobazamLannett Company, Inc.ANDACurrent
0527-5301ClobazamclobazamLannett Company, Inc.ANDACurrent
0527-5301ClobazamclobazamLannett Company, Inc.ANDACurrent
0527-5301ClobazamclobazamLannett Company, Inc.ANDACurrent
62135-527ClobazamClobazamChartwell RX, LLCANDACurrent
62135-527ClobazamClobazamChartwell RX, LLCANDACurrent